Skip to main content
PMC home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1959 Apr 1;80(7):546–549.

Imipramine (Tofranil ): A Safe, Effective Antidepressant Drug in Private Practice*

M Straker
PMCID: PMC1830976  PMID: 13629463

Full text

PDF
546

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTEMEIER L. H. Therapeutic results in mental hospitals with a minimum of professional personnel. Am J Psychiatry. 1956 Dec;113(6):515–518. doi: 10.1176/ajp.113.6.515. [DOI] [PubMed] [Google Scholar]
  2. FELDMAN P. E. The personal element in psychiatric research. Am J Psychiatry. 1956 Jul;113(1):52–54. doi: 10.1176/ajp.113.1.52. [DOI] [PubMed] [Google Scholar]
  3. KUHN R. The treatment of depressive states with G 22355 (imipramine hydrochloride). Am J Psychiatry. 1958 Nov;115(5):459–464. doi: 10.1176/ajp.115.5.459. [DOI] [PubMed] [Google Scholar]
  4. LEHMANN H. E., CAHN C. H., DE VERTEUIL R. L. The treatment of depressive conditions with imipramine (G 22355). Can Psychiatr Assoc J. 1958 Oct;3(4):155–164. doi: 10.1177/070674375800300401. [DOI] [PubMed] [Google Scholar]
  5. TUTEUR W. The double blind method: its pitfalls and fallacies. Am J Psychiatry. 1958 Apr;114(10):921–922. doi: 10.1176/ajp.114.10.921. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES